Rodrigo A. Fraga-Silva

Author

Also Known As

Fraga-Silva, Rodrigo, Fraga-Silva, Rodrigo A., R. Fraga-Silva, R.A. Fraga-Silva, Rodrigo A Fraga-Silva, Rodrigo A Fraga‐Silva, Rodrigo A. Fraga-Silva, Rodrigo Araujo Fraga-Silva, Rodrigo Araújo Fraga-Silva, Rodrigo Araújo Fraga-Silva

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de Minas Gerais University of Florida Max Delbrück Center Louisiana State University

About

Rodrigo A. Fraga-Silva is an author at Universidade Federal de Minas Gerais specializing in medicine, physiology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	416
2	Biochemistry	2	2	206
3	Engineering	1	1	16
4	Natural Sciences	1	1	96
5	Public Health	1	1	110

Rodrigo A. Fraga-Silva

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Discovery and Characterization of Alamandine Roberto Queiroga Lautner, Daniel Campos Villela, Rodrigo A. Fraga-Silva, Circulation Research	2013	424
The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension Vinayak Shenoy, Anderson J. Ferreira, Yanfei Qi, American Journal of Respiratory and Critical Care Medicine	2010	276
Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models Vinayak Shenoy, Altin Gjymishka, Yagna Jarajapu, American Journal of Respiratory and Critical Care Medicine	2013	173
The Antithrombotic Effect of Angiotensin-(1-7) Involves Mas-Mediated NO Release from Platelets Rodrigo A. Fraga-Silva, Sérgio Veloso Brant Pinheiro, Andrey Christian Costa Gonçalves, Molecular Medicine	2008	146
ACE2 Activation Promotes Antithrombotic Activity Rodrigo A. Fraga-Silva, Brian S. Sorg, Mamta Wankhede, Molecular Medicine	2010	133
Vascular Relaxation, Antihypertensive Effect, and Cardioprotection of a Novel Peptide Agonist of the Mas Receptor Silvia Quintão Savergnini, Merav Beiman, Roberto Queiroga Lautner, Hypertension HypertensionMas ReceptorIschemia ReperfusionCardiovascular PharmacologyPharmacotherapy	2010	130
Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases Anderson J. Ferreira, Vinayak Shenoy, Yanfei Qi, Experimental Physiology Acute Lung InjuryHypertensionLung InflammationCardiovascular PharmacologyRenal Inflammation	2010	110
An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect Rodrigo A. Fraga-Silva, Fabiana P. Costa‐Fraga, Frederico B. De Sousa, Clinics	2011	105
Angiotensin-Converting Enzyme 2 Activation Improves Endothelial Function Rodrigo A. Fraga-Silva, Fabiana P. Costa‐Fraga, Tatiane M. Murça, Hypertension InflammationMolecular PharmacologyHypertensionAngiogenesisCardiovascular Disease	2013	96
New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis Anderson J. Ferreira, Tatiane M. Murça, Rodrigo A. Fraga-Silva, International Journal of Hypertension	2012	79

Page 1